Bradykinin-induced cell migration and COX-2 production mediated by the bradykinin B1 receptor in glioma cells

Journal of Cellular Biochemistry

Volumn 110, Issue 1, 2010, Pages 141-150

  Lu, Dah Yuu ^a   Leung, Yuk Man ^a   Huang, Ssu Ming ^a,b   Wong, Kar Lok ^a  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

AKT; AP 1; Bradykinin; COX 2; Migration

Indexed keywords

BRADYKININ; BRADYKININ B1 RECEPTOR; CYCLOOXYGENASE 2; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE P85 SUBUNIT; PROTEIN KINASE B; SERINE; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; UPREGULATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; BRADYKININ; CELL LINE, TUMOR; CELL MOVEMENT; CYCLOOXYGENASE 2; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RECEPTOR, BRADYKININ B1; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1; UP-REGULATION;

EID: 77951722419     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22520     Document Type: Article

References (48)

1. Abbott NJ. 2000. Inflammatory mediators and modulation of blood-brain barrier permeability. Cell Mol Neurobiol 20:131-147. (Pubitemid 30091452)
2. Boiardi A, Silvani A, Milanesi I, Botturi M, Broggi G. 1991. Primary glial tumor patients treated by combining cis-platin and etoposide. J Neurooncol 11:165-170.
3. Bradbury DA, Corbett L, Knox AJ. 2004. PI 3-kinase and MAP kinase regulate bradykinin induced prostaglandin E(2) release in human pulmonary artery by modulating COX-2 activity. FEBS Lett 560:30-34. (Pubitemid 38264288)
4. Bradbury DA, Newton R, Zhu YM, Stocks J, Corbett L, Holland ED, Pang LH, Knox AJ. 2002. Effect of bradykinin, TGF-beta1, IL-1beta, and hypoxia on COX-2 expression in pulmonary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 283:L717-L725.
5. Brian JE Jr, Faraci FM, Moore SA. 2001. COX-2-dependent delayed dilatation of cerebral arterioles in response to bradykinin. Am J Physiol Heart Circ Physiol 280:H2023-H2029. (Pubitemid 32433779)
6. Chen BC, Kang JC, Lu YT, Hsu MJ, Liao CC, Chiu WT, Yeh FL, Lin CH. 2009. Rac1 regulates peptidoglycan-induced nuclear factor-kappaB activation and cyclooxygenase-2 expression in RAW 264.7 macrophages by activating the phosphatidylinositol 3-kinase/Akt pathway. Mol Immunol 46:1179-1188.
7. Christiansen SC, Eddleston J, Woessner KM, Chambers SS, Ye R, Pan ZK, Zuraw BL. 2002. Up-regulation of functional kinin B1 receptors in allergic airway inflammation. J Immunol 169:2054-2060. (Pubitemid 34857670)
8. Cohen BL, Gomez P, Omori Y, Duncan RC, Civantos F, Soloway MS, Lokeshwar VB, Lokeshwar BL. 2006. Cyclooxygenase-2 (COX-2) expression is an independent predictor of prostate cancer recurrence. Int J Cancer 119:1082-1087. (Pubitemid 44116917)
9. Cohen MV, Philipp S, Krieg T, Cui L, Kuno A, Solodushko V, Downey JM. 2007. Preconditioning-mimetics bradykinin and DADLE activate PI3-kinase through divergent pathways. J Mol Cell Cardiol 42:842-851. (Pubitemid 46527594)
10. Dannenberg AJ, Lippman SM, Mann JR, Subbaramaiah K, DuBois RN. 2005. Cyclooxygenase-2 and epidermal growth factor receptor: Pharmacologic targets for chemoprevention. J Clin Oncol 23:254-266. (Pubitemid 46206877)
11. Delmas P, Wanaverbecq N, Abogadie FC, Mistry M, Brown DA. 2002. Signaling microdomains define the specificity of receptor-mediated InsP(3) pathways in neurons. Neuron 34:209-220. (Pubitemid 34442564)
12. Franke TF, Kaplan DR, Cantley LC, Toker A. 1997. Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate. Science 275:665-668. (Pubitemid 27061333)
13. Fredholm BB, Altiok N. 1994. Adenosine A2B receptor signalling is altered by stimulation of bradykinin or interleukin receptors in astroglioma cells. Neurochem Int 25:99-102. (Pubitemid 2114969)
14. Hou CH, Hsiao YC, Fong YC, Tang CH. 2009. Bone morphogenetic protein-2 enhances the motility of chondrosarcoma cells via activation of matrix metalloproteinase-13. Bone 44:233-242.
15. Hsieh HL, Wang HH, Wu CY, Jou MJ, Yen MH, Parker P, Yang CM. 2007. BK-induced COX-2 expression via PKC-delta-dependent activation of p42/p44 MAPK and NF-kappaB in astrocytes. Cell Signal 19:330-340. (Pubitemid 44969982)
16. Hsieh HL, Wu CB, Sun CC, Liao CH, Lau YT, Yang CM. 2006. Sphingosine-1-phosphate induces COX-2 expression via PI3K/Akt and p42/p44 MAPK pathways in rat vascular smooth muscle cells. J Cell Physiol 207:757-766.
17. Hsieh HL, Wu CY, Yang CM. 2008. Bradykinin induces matrix metalloproteinase-9 expression and cell migration through a PKC-delta-dependent ERK/Elk-1 pathway in astrocytes. Glia 56:619-632.
18. Ifuku M, Farber K, Okuno Y, Yamakawa Y, Miyamoto T, Nolte C, Merrino VF, Kita S, Iwamoto T, Komuro I, Wang B, Cheung G, Ishikawa E, Ooboshi H, Bader M, Wada K, Kettenmann H, Noda M. 2007. Bradykinin-induced microglial migration mediated by B1-bradykinin receptors depends on Ca2+ influx via reverse-mode activity of the Na+/Ca2+ exchanger. J Neurosci 27:13065-13073.
19. Inamura T, Black KL. 1994. Bradykinin selectively opens blood-tumor barrier in experimental brain tumors. J Cereb Blood Flow Metab 14:862-870. (Pubitemid 24266539)
20. Kamiya T, Katayama Y, Kashiwagi F, Terashi A. 1993. The role of bradykinin in mediating ischemic brain edema in rats. Stroke 24:571-575, discussion 575-576. (Pubitemid 23100745)
21. Khor LY, Bae K, Pollack A, Hammond ME, Grignon DJ, Venkatesan VM, Rosenthal SA, Ritter MA, Sandler HM, Hanks GE, Shipley WU, Dicker AP. 2007. COX-2 expression predicts prostate-cancer outcome: Analysis of data from the RTOG 92-02 trial. Lancet Oncol 8:912-920. (Pubitemid 47495777)
22. Kondo Y, Hollingsworth EF, Kondo S. 2004. Molecular targeting for malignant gliomas (Review). Int J Oncol 24:1101-1109.
23. Koul D, Shen R, Bergh S, Sheng X, Shishodia S, Lafortune TA, Lu Y, de Groot JF, Mills GB, Yung WK. 2006. Inhibition of Akt survival pathway by a small-molecule inhibitor in human glioblastoma. Mol Cancer Ther 5:637-644.
24. Lehmberg J, Beck J, Baethmann A, Uhl E. 2003. Bradykinin antagonists reduce leukocyte-endothelium interactions after global cerebral ischemia. J Cereb Blood Flow Metab 23:441-448. (Pubitemid 36403026)
25. Liu XH, Kirschenbaum A, Yao S, Lee R, Holland JF, Levine AC. 2000. Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo. J Urol 164:820-825. (Pubitemid 30637640)
26. Lo EJ, Green PG, Miao FJ, Relchling DB, Levine JD. 1999. Bradykinin-induced neurogenic migration of neutrophils into the rat knee joint. Neuroreport 10:3821-3824.
27. Lu DY, Tang CH, Yeh WL, Wong KL, Lin CP, Chen YH, Lai CH, Chen YF, Leung YM, Fu WM. 2009. SDF-1alpha up-regulates interleukin-6 through CXCR4, PI3K/Akt, ERK, and NF-kappaB-dependent pathway in microglia. Eur J Pharmacol 613:146-154.
28. Mukherjee R, Edwards J, Underwood MA, Bartlett JM. 2005. The relationship between angiogenesis and cyclooxygenase-2 expression in prostate cancer. BJU Int 96:62-66. (Pubitemid 40942870)
29. Murata H, Kawano S, Tsuji S, Tsuji M, Sawaoka H, Kimura Y, Shiozaki H, Hori M. 1999. Cyclooxygenase-2 overexpression enhances lymphatic invasion and metastasis in human gastric carcinoma. Am J Gastroenterol 94:451-455. (Pubitemid 29084668)
30. Naraba H, Ueno A, Kosugi Y, Yoshimura M, Murakami M, Kudo I, Oh-ishi S. 1998. Agonist stimulation of B1 and B2 kinin receptors causes activation of the MAP kinase signaling pathway, resulting in the translocation of AP-1 in HEK 293 cells. FEBS Lett 435:96-100. (Pubitemid 28432022)
31. Noda M, Kariura Y, Amano T, Manago Y, Nishikawa K, Aoki S, Wada K. 2003. Expression and function of bradykinin receptors in microglia. Life Sci 72:1573-1581. (Pubitemid 36124020)
32. Noda M, Sasaki K, Ifuku M, Wada K. 2007. Multifunctional effects of bradykinin on glial cells in relation to potential anti-inflammatory effects. Neurochem Int 51:185-191. (Pubitemid 47176715)
33. Nomura T, Inamura T, Black KL. 1994. Intracarotid infusion of bradykinin selectively increases blood-tumor permeability in 9L and C6 brain tumors. Brain Res 659:62-66. (Pubitemid 24292845)
34. Pan ZK, Christiansen SC, Ptasznik A, Zuraw BL. 1999. Requirement of phosphatidylinositol 3-kinase activity for bradykinin stimulation of NF-kappaB activation in cultured human epithelial cells. J Biol Chem 274:9918-9922. (Pubitemid 129518270)
35. Stephens GJ, Cholewinski AJ, Wilkin GP, Djamgoz MB. 1993a. Calcium-mobilizing and electrophysiological effects of bradykinin on cortical astrocyte subtypes in culture. Glia 9:269-279.
36. Stephens GJ, Marriott DR, Djamgoz MB, Wilkin GP. 1993b. Electrophysiological and biochemical evidence for bradykinin receptors on cultured rat cortical oligodendrocytes. Neurosci Lett 153:223-226.
37. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO. 2005. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987-996.
38. Su CM, Lu DY, Hsu CJ, Chen HT, Huang CY, Yang WH, Su YC, Yang SN, Fong YC, Tseng WP, Tang CH. 2009a. Glial cell-derived neurotrophic factor increases migration of human chondrosarcoma cells via ERK and NF-kappaB pathways. J Cell Physiol 220:499-507.
39. Su J, Cui M, Tang Y, Zhou H, Liu L, Dong Q. 2009b. Blockade of bradykinin B2 receptor more effectively reduces postischemic blood-brain barrier disruption and cytokines release than B1 receptor inhibition. Biochem Biophys Res Commun 388:205-211.
40. Tang CH, Yang RS, Huang TH, Lu DY, Chuang WJ, Huang TF, Fu WM. 2006. Ultrasound stimulates cyclooxygenase-2 expression and increases bone formation through integrin, focal adhesion kinase, phosphatidylinositol 3-kinase, and Akt pathway in osteoblasts. Mol Pharmacol 69:2047-2057.
41. Taub JS, Guo R, Leeb-Lundberg LM, Madden JF, Daaka Y. 2003. Bradykinin receptor subtype 1 expression and function in prostate cancer. Cancer Res 63:2037-2041. (Pubitemid 36538604)
42. Thomas SM, Bhola NE, Zhang Q, Contrucci SC, Wentzel AL, Freilino ML, Gooding WE, Siegfried JM, Chan DC, Grandis JR. 2006. Cross-talk between G protein-coupled receptor and epidermal growth factor receptor signaling pathways contributes to growth and invasion of head and neck squamous cell carcinoma. Cancer Res 66:11831-11839. (Pubitemid 46094195)
43. Wang W, Bergh A, Damber JE. 2005. Cyclooxygenase-2 expression correlates with local chronic inflammation and tumor neovascularization in human prostate cancer. Clin Cancer Res 11:3250-3256. (Pubitemid 40627872)
44. Wu J, Akaike T, Hayashida K, Miyamoto Y, Nakagawa T, Miyakawa K, Muller-Esterl W, Maeda H. 2002. Identification of bradykinin receptors in clinical cancer specimens and murine tumor tissues. Int J Cancer 98:29-35. (Pubitemid 34113414)
45. Yamaguchi J, Kusano KF, Masuo O, Kawamoto A, Silver M, Murasawa S, Bosch-Marce M, Masuda H, Losordo DW, Isner JM, Asahara T. 2003. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 107:1322-1328. (Pubitemid 36314418)
46. Zhang D, Li J, Song L, Ouyang W, Gao J, Huang C. 2008a. A JNK1/AP-1-dependent, COX-2 induction is implicated in 12-O-tetradecanoylphorbol- 13-acetate-induced cell transformation through regulating cell cycle progression. Mol Cancer Res 6:165-174. (Pubitemid 351378176)
47. Zhang W, Bhola N, Kalyankrishna S, Gooding W, Hunt J, Seethala R, Grandis JR, Siegfried JM. 2008b. Kinin b2 receptor mediates induction of cyclooxygenase-2 and is overexpressed in head and neck squamous cell carcinomas. Mol Cancer Res 6:1946-1956.
48. Zhao Y, Xue Y, Liu Y, Fu W, Jiang N, An P, Wang P, Yang Z, Wang Y. 2005. Study of correlation between expression of bradykinin B2 receptor and pathological grade in human gliomas. Br J Neurosurg 19:322-326.